HTG MOLECULAR DIAGNOSTICS IN - COM (HTGM)

CUSIP: 40434H104

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
1,893,591
Share change
-549,724
Total reported value
$3,218,350
Price per share
$1.70
Number of holders
21
Value change
-$2,313,892
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 40434H104?
CUSIP 40434H104 identifies HTGM - HTG MOLECULAR DIAGNOSTICS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HTG MOLECULAR DIAGNOSTICS IN - COM (HTGM) as of Q3 2017

As of 30 Sep 2017, HTG MOLECULAR DIAGNOSTICS IN - COM (HTGM) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,893,591 shares. The largest 10 holders included FMR LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, Laurion Capital Management LP, PANAGORA ASSET MANAGEMENT INC, Virtu Financial LLC, PUTNAM INVESTMENTS LLC, TWO SIGMA SECURITIES, LLC, Bank of New York Mellon Corp, and MILLENNIUM MANAGEMENT LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.